SCHEMBL30830926

SCHEMBL30830926

CN1C[C@H](Nc2cnn(C)c(=O)c2Cl)C[C@H](c2ccc(C(=O)N3CCC4(CC3)CCN(c3ccc5c(c3)C(=O)N(C3CCC(=O)NC3=O)C5=O)CC4)cc2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 5/20 0.48
▸ KAT2B Q92831 8/20 0.48
▸ BRD9 Q9H8M2 3/20 0.48
▸ CRBN Q96SW2 7/20 0.42
▸ HPGDS O60760 2/20 0.42
▸ PLK4 O00444 1/20 0.42
▸ BTK Q06187 1/20 0.39
▸ MAP4K1 Q92918 1/20 0.38
▸ BRD1 O95696 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ BRPF1 P55201 1/20 0.38
▸ BPTF Q12830 1/20 0.38
▸ KAT2A Q92830 1/20 0.38
▸ BRD7 Q9NPI1 1/20 0.38
▸ BAZ2B Q9UIF8 1/20 0.38
▸ BRPF3 Q9ULD4 1/20 0.38
▸ CCNC P24863 1/20 0.38
▸ CDK8 P49336 1/20 0.38
▸ IRAK1 P51617 1/20 0.38
▸ NTRK3 Q16288 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830473 0.96 KAT2B (0.51) ARKAT2BBRD9CRBNHPGDS
SCHEMBL30830651 0.93 KAT2B (0.48) ARKAT2BBRD9CRBNHPGDS
SCHEMBL30830618 0.89 KAT2B (0.47) ARKAT2BBRD9CRBNHPGDS
SCHEMBL30830849 0.89 KAT2B (0.51) ARKAT2BBRD9CRBNHPGDS
SCHEMBL30830888 0.88 KAT2B (0.48) ARKAT2BBRD9CRBNHPGDS
SCHEMBL30830610 0.88 KAT2B (0.53) KAT2BBRD9CRBNBRD1ACHE
SCHEMBL30830572 0.88 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830835 0.88 KAT2B (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831074 0.88 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830776 0.88 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback